Tadd Seaton Wessel
Vorstandsvorsitzender bei Petrichor Healthcare Capital Management LP
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Fauzia M. Khan | M | - |
Persivia, Inc.
Persivia, Inc. Packaged SoftwareTechnology Services Persivia, Inc. provides a clinical decision support and reporting analytics platform. It aggregates, analyzes and reports clinical data sets in the healthcare industry. The firm offers patient-centric clinical decision support, population health management, intelligent order sets, disease surveillance and regulatory reporting services. The company was founded by Mansoor Khan and is headquartered in Lowell, MA. | - |
Howard W. Sams | M | - |
Health Outlook Corp.
Health Outlook Corp. Information Technology ServicesTechnology Services Health Outlook Corp. is a health prediction company that uses modern proteomics to better predict health events and improve health outcomes. The company is based in New York, NY. The company's proprietary algorithms use statistical models of mortality risk that incorporate traditional factors and modern proteomic markers. Health Outlook is launching businesses that leverage its algorithms in the financial services and health systems markets. Health Outlook was founded by Tim Opler, and the CEO is Howard W. Sams. | - |
Mansoor Khan | M | - |
Persivia, Inc.
Persivia, Inc. Packaged SoftwareTechnology Services Persivia, Inc. provides a clinical decision support and reporting analytics platform. It aggregates, analyzes and reports clinical data sets in the healthcare industry. The firm offers patient-centric clinical decision support, population health management, intelligent order sets, disease surveillance and regulatory reporting services. The company was founded by Mansoor Khan and is headquartered in Lowell, MA. | - |
John J. Rydzewski | M | 71 |
Health Outlook Corp.
Health Outlook Corp. Information Technology ServicesTechnology Services Health Outlook Corp. is a health prediction company that uses modern proteomics to better predict health events and improve health outcomes. The company is based in New York, NY. The company's proprietary algorithms use statistical models of mortality risk that incorporate traditional factors and modern proteomic markers. Health Outlook is launching businesses that leverage its algorithms in the financial services and health systems markets. Health Outlook was founded by Tim Opler, and the CEO is Howard W. Sams. | - |
Baabur M S Khondker | M | - |
Petrichor Healthcare Capital Management LP
Petrichor Healthcare Capital Management LP Investment ManagersFinance Petrichor Healthcare Capital Management LP (Petrichor) is a private equity firm founded in 2016 by Tadd Wessel. The firm headquartered in New York. | 4 Jahre |
David Katona | M | - |
Petrichor Healthcare Capital Management LP
Petrichor Healthcare Capital Management LP Investment ManagersFinance Petrichor Healthcare Capital Management LP (Petrichor) is a private equity firm founded in 2016 by Tadd Wessel. The firm headquartered in New York. | 3 Jahre |
Tim Opler | M | - |
Health Outlook Corp.
Health Outlook Corp. Information Technology ServicesTechnology Services Health Outlook Corp. is a health prediction company that uses modern proteomics to better predict health events and improve health outcomes. The company is based in New York, NY. The company's proprietary algorithms use statistical models of mortality risk that incorporate traditional factors and modern proteomic markers. Health Outlook is launching businesses that leverage its algorithms in the financial services and health systems markets. Health Outlook was founded by Tim Opler, and the CEO is Howard W. Sams. | - |
Sir Bruce E. Keogh | M | - |
Petrichor Healthcare Capital Management LP
Petrichor Healthcare Capital Management LP Investment ManagersFinance Petrichor Healthcare Capital Management LP (Petrichor) is a private equity firm founded in 2016 by Tadd Wessel. The firm headquartered in New York. | 3 Jahre |
Hayden Fownes | M | - |
Petrichor Healthcare Capital Management LP
Petrichor Healthcare Capital Management LP Investment ManagersFinance Petrichor Healthcare Capital Management LP (Petrichor) is a private equity firm founded in 2016 by Tadd Wessel. The firm headquartered in New York. | - |
Adam Morgan | M | 45 |
Health Outlook Corp.
Health Outlook Corp. Information Technology ServicesTechnology Services Health Outlook Corp. is a health prediction company that uses modern proteomics to better predict health events and improve health outcomes. The company is based in New York, NY. The company's proprietary algorithms use statistical models of mortality risk that incorporate traditional factors and modern proteomic markers. Health Outlook is launching businesses that leverage its algorithms in the financial services and health systems markets. Health Outlook was founded by Tim Opler, and the CEO is Howard W. Sams. | - |
Manuel Salvisberg | M | - |
ITM Isotope Technologies Munich SE
ITM Isotope Technologies Munich SE Pharmaceuticals: MajorHealth Technology ITM Isotope Technologies Munich SE is a German radiopharmaceutical biotech company that specializes in providing precise cancer radiotherapeutics and diagnostics to meet the needs of patients, clinicians, and partners. ITM Isotope Technologies Munich is based in Garching, DE, and has subsidiaries in Germany. The company aims to provide a new generation of radiomolecular precision therapeutics and diagnostics for hard-to-treat tumors. ITM has a broad precision oncology pipeline, including two phase III studies, combining the company's high-quality radioisotopes with a range of targeting molecules. The company benefits from its GMP infrastructure and expertise in sourcing, processing, and radiolabeling. The company was founded in 2004, and Steffen Schuster has been the CEO of the company since 2011. | - |
Oliver Buck | M | - |
ITM Isotope Technologies Munich SE
ITM Isotope Technologies Munich SE Pharmaceuticals: MajorHealth Technology ITM Isotope Technologies Munich SE is a German radiopharmaceutical biotech company that specializes in providing precise cancer radiotherapeutics and diagnostics to meet the needs of patients, clinicians, and partners. ITM Isotope Technologies Munich is based in Garching, DE, and has subsidiaries in Germany. The company aims to provide a new generation of radiomolecular precision therapeutics and diagnostics for hard-to-treat tumors. ITM has a broad precision oncology pipeline, including two phase III studies, combining the company's high-quality radioisotopes with a range of targeting molecules. The company benefits from its GMP infrastructure and expertise in sourcing, processing, and radiolabeling. The company was founded in 2004, and Steffen Schuster has been the CEO of the company since 2011. | 12 Jahre |
Patrick P. Lally | M | - |
Petrichor Healthcare Capital Management LP
Petrichor Healthcare Capital Management LP Investment ManagersFinance Petrichor Healthcare Capital Management LP (Petrichor) is a private equity firm founded in 2016 by Tadd Wessel. The firm headquartered in New York. | 6 Jahre |
Michael Beecham | M | - |
Petrichor Healthcare Capital Management LP
Petrichor Healthcare Capital Management LP Investment ManagersFinance Petrichor Healthcare Capital Management LP (Petrichor) is a private equity firm founded in 2016 by Tadd Wessel. The firm headquartered in New York. | 7 Jahre |
Edward Cahill | M | 71 |
Persivia, Inc.
Persivia, Inc. Packaged SoftwareTechnology Services Persivia, Inc. provides a clinical decision support and reporting analytics platform. It aggregates, analyzes and reports clinical data sets in the healthcare industry. The firm offers patient-centric clinical decision support, population health management, intelligent order sets, disease surveillance and regulatory reporting services. The company was founded by Mansoor Khan and is headquartered in Lowell, MA. | - |
Ron Zwanziger | M | 70 |
Persivia, Inc.
Persivia, Inc. Packaged SoftwareTechnology Services Persivia, Inc. provides a clinical decision support and reporting analytics platform. It aggregates, analyzes and reports clinical data sets in the healthcare industry. The firm offers patient-centric clinical decision support, population health management, intelligent order sets, disease surveillance and regulatory reporting services. The company was founded by Mansoor Khan and is headquartered in Lowell, MA. | - |
Stefan Sanktjohanser | M | - |
ITM Isotope Technologies Munich SE
ITM Isotope Technologies Munich SE Pharmaceuticals: MajorHealth Technology ITM Isotope Technologies Munich SE is a German radiopharmaceutical biotech company that specializes in providing precise cancer radiotherapeutics and diagnostics to meet the needs of patients, clinicians, and partners. ITM Isotope Technologies Munich is based in Garching, DE, and has subsidiaries in Germany. The company aims to provide a new generation of radiomolecular precision therapeutics and diagnostics for hard-to-treat tumors. ITM has a broad precision oncology pipeline, including two phase III studies, combining the company's high-quality radioisotopes with a range of targeting molecules. The company benefits from its GMP infrastructure and expertise in sourcing, processing, and radiolabeling. The company was founded in 2004, and Steffen Schuster has been the CEO of the company since 2011. | 4 Jahre |
Gunther Strothe | M | - |
ITM Isotope Technologies Munich SE
ITM Isotope Technologies Munich SE Pharmaceuticals: MajorHealth Technology ITM Isotope Technologies Munich SE is a German radiopharmaceutical biotech company that specializes in providing precise cancer radiotherapeutics and diagnostics to meet the needs of patients, clinicians, and partners. ITM Isotope Technologies Munich is based in Garching, DE, and has subsidiaries in Germany. The company aims to provide a new generation of radiomolecular precision therapeutics and diagnostics for hard-to-treat tumors. ITM has a broad precision oncology pipeline, including two phase III studies, combining the company's high-quality radioisotopes with a range of targeting molecules. The company benefits from its GMP infrastructure and expertise in sourcing, processing, and radiolabeling. The company was founded in 2004, and Steffen Schuster has been the CEO of the company since 2011. | 8 Jahre |
Udo Johannes Vetter | M | 69 |
ITM Isotope Technologies Munich SE
ITM Isotope Technologies Munich SE Pharmaceuticals: MajorHealth Technology ITM Isotope Technologies Munich SE is a German radiopharmaceutical biotech company that specializes in providing precise cancer radiotherapeutics and diagnostics to meet the needs of patients, clinicians, and partners. ITM Isotope Technologies Munich is based in Garching, DE, and has subsidiaries in Germany. The company aims to provide a new generation of radiomolecular precision therapeutics and diagnostics for hard-to-treat tumors. ITM has a broad precision oncology pipeline, including two phase III studies, combining the company's high-quality radioisotopes with a range of targeting molecules. The company benefits from its GMP infrastructure and expertise in sourcing, processing, and radiolabeling. The company was founded in 2004, and Steffen Schuster has been the CEO of the company since 2011. | 18 Jahre |
Steffen Schuster | M | 59 |
ITM Isotope Technologies Munich SE
ITM Isotope Technologies Munich SE Pharmaceuticals: MajorHealth Technology ITM Isotope Technologies Munich SE is a German radiopharmaceutical biotech company that specializes in providing precise cancer radiotherapeutics and diagnostics to meet the needs of patients, clinicians, and partners. ITM Isotope Technologies Munich is based in Garching, DE, and has subsidiaries in Germany. The company aims to provide a new generation of radiomolecular precision therapeutics and diagnostics for hard-to-treat tumors. ITM has a broad precision oncology pipeline, including two phase III studies, combining the company's high-quality radioisotopes with a range of targeting molecules. The company benefits from its GMP infrastructure and expertise in sourcing, processing, and radiolabeling. The company was founded in 2004, and Steffen Schuster has been the CEO of the company since 2011. | 13 Jahre |
Donald Berwick | M | 77 |
Petrichor Healthcare Capital Management LP
Petrichor Healthcare Capital Management LP Investment ManagersFinance Petrichor Healthcare Capital Management LP (Petrichor) is a private equity firm founded in 2016 by Tadd Wessel. The firm headquartered in New York. | - |
Peter Greenleaf | M | 54 |
Petrichor Healthcare Capital Management LP
Petrichor Healthcare Capital Management LP Investment ManagersFinance Petrichor Healthcare Capital Management LP (Petrichor) is a private equity firm founded in 2016 by Tadd Wessel. The firm headquartered in New York. | - |
Raymond Schinazi | M | 74 |
Petrichor Healthcare Capital Management LP
Petrichor Healthcare Capital Management LP Investment ManagersFinance Petrichor Healthcare Capital Management LP (Petrichor) is a private equity firm founded in 2016 by Tadd Wessel. The firm headquartered in New York. | - |
Michael Lee-Chin | M | 73 |
ITM Isotope Technologies Munich SE
ITM Isotope Technologies Munich SE Pharmaceuticals: MajorHealth Technology ITM Isotope Technologies Munich SE is a German radiopharmaceutical biotech company that specializes in providing precise cancer radiotherapeutics and diagnostics to meet the needs of patients, clinicians, and partners. ITM Isotope Technologies Munich is based in Garching, DE, and has subsidiaries in Germany. The company aims to provide a new generation of radiomolecular precision therapeutics and diagnostics for hard-to-treat tumors. ITM has a broad precision oncology pipeline, including two phase III studies, combining the company's high-quality radioisotopes with a range of targeting molecules. The company benefits from its GMP infrastructure and expertise in sourcing, processing, and radiolabeling. The company was founded in 2004, and Steffen Schuster has been the CEO of the company since 2011. | 5 Jahre |
Joseph Konowiecki | M | 70 |
Health Outlook Corp.
Health Outlook Corp. Information Technology ServicesTechnology Services Health Outlook Corp. is a health prediction company that uses modern proteomics to better predict health events and improve health outcomes. The company is based in New York, NY. The company's proprietary algorithms use statistical models of mortality risk that incorporate traditional factors and modern proteomic markers. Health Outlook is launching businesses that leverage its algorithms in the financial services and health systems markets. Health Outlook was founded by Tim Opler, and the CEO is Howard W. Sams. | - |
Peter Koerte | M | - |
Health Outlook Corp.
Health Outlook Corp. Information Technology ServicesTechnology Services Health Outlook Corp. is a health prediction company that uses modern proteomics to better predict health events and improve health outcomes. The company is based in New York, NY. The company's proprietary algorithms use statistical models of mortality risk that incorporate traditional factors and modern proteomic markers. Health Outlook is launching businesses that leverage its algorithms in the financial services and health systems markets. Health Outlook was founded by Tim Opler, and the CEO is Howard W. Sams. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 19 | 73,08% |
Deutschland | 7 | 26,92% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Tadd Seaton Wessel
- Persönliches Netzwerk